Bayshore Pharmaceuticals

08/10/2023

Rainy day Team outing! And the boss is killing it!!

05/30/2023

We hope to see you in San Diego.
Reach out to Dena Mando, VP Sales & Marketing for an appointment. Dena.mando@bayshoreus.com

11/15/2021

SHORT HILLS, N.J.--(BUSINESS WIRE)--Bayshore Pharmaceuticals, LLC is pleased to introduce three new FDA-approved products to their expanding portfolio.

Metolazone Tablets USP, 2.5mg, 5mg and 10 mg, is the generic equivalent of Zaroxolyn Tablets. It is available by prescription only and is indicated for the treatment of high blood pressure and fluid retention.

Etodolac Immediate Release Tablets USP, 400 mg and 500 mg, is the generic equivalent of Lodine Tablets. Etodolac is a nonsteroidal anti-inflammatory drug and only available by prescription.

Ketotifen Fumarate Ophthalmic Solution, 0.035% (OTC & RX) is the generic equivalent of Zaditor. It is an antihistamine that is indicated for the treatment of itchy eyes. Ketotifen is Bayshore Pharmaceutical’s first ANDA approved product that is available by prescription or as an OTC in the Bayshore Label.

See full article:

Bayshore Pharmaceuticals, LLC is pleased to introduce three new FDA-approved products to their expanding portfolio. Metolazone Tablets USP, 2.5mg, 5mg

11/11/2021

Bayshore remains proud of our association with Beximco Pharmaceuticals and appreciates their efforts!

11/11/2021

Bayshore remains proud of our association with Beximco and appreciates their efforts

10/22/2021

Tune in to "Inside the blueprint" on Saturday October 23rd at 1:00pm to hear Mark Moshier, President of Bayshore Pharmaceuticals, LLC discuss Generic Pharmaceuticals.

Facebook Premiere: https://www.facebook.com/events/181926070766443/

YouTube Premiere: https://www.youtube.com/watch?v=ZGOi70KBPFw

10/20/2021

Tune in to Inside the Saturday October 23rd at 1:00pm to hear Mark Moshier, President of Bayshore Pharmaceuticals discuss Generic Pharmaceuticals.

https://bayshoreus.com/bayshore-pharmaceuticals-as-featured-on-inside-the-blueprint-local-ny/

09/22/2021

Proud to be a partner of this world class organization.

https://www.forbes.com/sites/beximco-group/2021/09/01/setting-the-bar-high-for-generic-medicines/?sh=37f90f99124d&fbclid=IwAR3QG_IVMDQq6o7vFmjsm0TygK5SKGmSGV8YQR_ytd6wwEmaZ02TveGPxfc

As the pandemic upended the healthcare supply chain over the past year, one company in Bangladesh did not only strive to ensure the continued distribution of medicines across the country, but also introduced its own antidote against Covid-19.

12/22/2020

NEW ANDA APPROVAL - Etodolac & Etodolac ER

Bayshore Pharmaceuticals, LLC Granted Etodolac ANDA Approvals
December 22, 2020 – Short Hills, NJ
Bayshore Pharmaceuticals is pleased to announce that it has been granted FDA-approval for its Abbreviated New Drug Applications (ANDA) for both Etodolac Immediate Release Tablets (400 mg & 500 mg) and Etodolac Extended Release Tablets (400 mg, 500 mg & 600 mg). Commercial product launch is expected to be during the first half of 2021.

10/15/2020

Bayshore partner Beximco Pharmaceuticals Ltd has been awarded the CPhI Pharma Award 2020
October 15, 2020. Beximco Pharmaceutical Ltd has been awarded the CPhI Pharma Award 2020 under the category " Innovation in Response to Covid-19". CPhI Pharma Awards are among the most prestigious recognitions in the pharmaceutical industry.

Beximco Pharma became the first in the world to launch generic Remdesivir as Bemsivir

03/17/2020

03/17/2020

Bayshore is pleased to announce the introduction of our new products: Cyproheptadine HCl, Pindolol, and Sotalol HCl AF. Welcome to the family!